Cargando…
Hepatic steatosis secondary to capecitabine: a case report
INTRODUCTION: There are no known case reports of hepatic steatosis caused by oral fluoropyrimidines such as capecitabine. With increasing use of capecitabine since its approval for the treatment of metastatic colon cancer in 2001, and more recently for adjuvant treatment of colon cancer and treatmen...
Autores principales: | Chin, Sheray N, Kim, Tae K, Siu, Lillian L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916012/ https://www.ncbi.nlm.nih.gov/pubmed/24576340 http://dx.doi.org/10.1186/1752-1947-4-227 |
Ejemplares similares
-
Ileitis Secondary to Oral Capecitabine Treatment?
por: Radwan, Rami, et al.
Publicado: (2012) -
Multiple drugs: Hepatic steatosis: case report
Publicado: (2021) -
Hepatic steatosis with mass effect: A case report
por: Hu, Na, et al.
Publicado: (2022) -
A case report of multinodular hepatic steatosis mimicking pseudotumors of the liver
por: Burko, Pavel, et al.
Publicado: (2022) -
A Case of Capecitabine-Induced Sarcoidosis
por: Kang, Shin Myung, et al.
Publicado: (2012)